Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Charles River Laboratories cooperation agreement with Elliott
We are advising Charles River on the agreement
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
3SBio Inc. HK$5.5 Billion (US$711.6 Million) Initial Public Offering
Davis Polk advised the underwriters as joint global coordinators on the initial public offering and listing on the Main…
Bio-Reference Laboratories $1.47 billion acquisition by OPKO Health
Davis Polk is advising Bio-Reference Laboratories, Inc. in connection with its approximately $1.47 billion acquisition by…
Hologic, Inc. $2.5 Billion Senior Secured Credit Facilities Refinancing
Davis Polk advised the administrative agent in connection with the refinancing of Hologic, Inc.’s existing senior secured…
Davis Polk Advises Auris Medical Holding AG on Its Offering of Common Shares
Davis Polk advised Auris Medical Holding AG (“Auris Medical”) on its $25.1 million public offering of 5,275,000 of its…
Galapagos NV €278.7 Million Global Offering Of Ordinary Shares
Davis Polk advised the several underwriters, in connection with Galapagos NV’s global offering of 7,532,499 of its ordinary…
Anthem $1.25 Billion Equity Units Offering
Davis Polk advised the joint book-running managers in connection with a registered public offering by Anthem, Inc. of $1.25…
Laboratory Corporation of America Holdings $2.9 Billion Senior Notes Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters on a public offering by…
Warner Chilcott $8.5 billion acquisition by Actavis
Davis Polk is advising Warner Chilcott plc in connection with its approximately $8.5 billion acquisition by Actavis, Inc. in…
HHS-OIG Drops Potential Action Against Howard Solomon
On August 5, 2011, the Office of Inspector General for the Department of Health and Human Services dropped a potential…
Successful patent litigation jury verdict for VNUS Medical
Davis Polk represented VNUS Medical in patent infringement litigation since 2005 in the Northern District of California…